Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 421

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Surgical Treatment of Moderate Ischemic Mitral Regurgitation

Open access
Smith, Peter K., Puskas, John D., Ascheim, Deborah D., Voisine, Pierre, Gelijns, Annetine C., Moskowitz, Alan J., Hung, Judy W., Parides, Michael K., Ailawadi, Gorav, Perrault, Louis P., Acker, Michael A., Argenziano, Michael, Thourani, Vinod, Gammie, James S., Miller, Marissa A., Pagé, Pierre, Overbey, Jessica R., Bagiella, Emilia, Dagenais, François, Blackstone, Eugene H., Kron, Irving L., Goldstein, Daniel J., Rose, Eric A., Moquete, Ellen G., Jeffries, Neal, Gardner, Timothy J., O'Gara, Patrick T., Alexander, John H., Michler, Robert E.·2014·New England Journal of Medicine

Abstract

BACKGROUND: Ischemic mitral regurgitation is associated with increased mortality and morbidity. For surgical patients with moderate regurgitation, the benefits of adding mitral-valve repair to coronary-artery bypass grafting (CABG) are uncertain. METHODS: We randomly assigned 301 patients with moderate ischemic mitral regurgitation to CABG alone or CABG plus mitral-valve repair (combined procedure). The primary end point was the left ventricular end-systolic volume index (LVESVI), a measure of left ventricular remodeling, at 1 year. This end point was assessed with the use of a Wilcoxon rank-sum test in which deaths were categorized as the lowest LVESVI rank. RESULTS: At 1 year, the mean LVESVI among surviving patients was 46.1±22.4 ml per square meter of body-surface area in the CABG-alone group and 49.6±31.5 ml per square meter in the combined-procedure group (mean change from baseline, -9.4 and -9.3 ml per square meter, respectively). The rate of death was 6.7% in the combined-procedure group and 7.3% in the CABG-alone group (hazard ratio with mitral-valve repair, 0.90; 95% confidence interval, 0.38 to 2.12; P=0.81). The rank-based assessment of LVESVI at 1 year (incorporating deaths) showed no significant between-group difference (z score, 0.50; P=0.61). The addition of mitral-valve repair was associated with a longer bypass time (P<0.001), a longer hospital stay after surgery (P=0.002), and more neurologic events (P=0.03). Moderate or severe mitral regurgitation was less common in the combined-procedure group than in the CABG-alone group (11.2% vs. 31.0%, P<0.001). There were no significant between-group differences in major adverse cardiac or cerebrovascular events, deaths, readmissions, functional status, or quality of life at 1 year. CONCLUSIONS: In patients with moderate ischemic mitral regurgitation, the addition of mitral-valve repair to CABG did not result in a higher degree of left ventricular reverse remodeling. Mitral-valve repair was associated with a reduced prevalence of moderate or severe mitral regurgitation but an increased number of untoward events. Thus, at 1 year, this trial did not show a clinically meaningful advantage of adding mitral-valve repair to CABG. Longer-term follow-up may determine whether the lower prevalence of mitral regurgitation translates into a net clinical benefit. (Funded by the National Institutes of Health and the Canadian Institutes of Health Research; ClinicalTrials.gov number, NCT00806988.).

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmoa1410490

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Research works printed but not linked: 39

  1. 10.1161/01.cir.0000441139.02102.80 · DOI · Paper page
  2. 10.1161/01.CIR.0000151097.30779.04 · DOI · Paper page
  3. 10.1093/eurheartj/ehm469 · DOI
  4. 10.1161/01.CIR.96.3.827 · DOI · Paper page
  5. 10.1161/CIRCULATIONAHA.113.005223 · DOI
  6. 10.1016/j.jacc.2004.10.030 · DOI · Paper page
  7. 10.1161/01.CIR.76.4.777 · doi:10.1161/01.cir.76.4.777
  8. 10.1016/0735-1097(92)90455-V · DOI · Paper page
  9. 10.1161/01.CIR.102.12.1400 · doi:10.1161/01.cir.102.12.1400
  10. 10.1067/mtc.2003.78 · doi:10.1067/mtc.2003.78
  11. 10.1016/j.athoracsur.2004.07.040 · doi:10.1016/j.athoracsur.2004.07.040
  12. Schroder JN, 2005, Circulation, 112, I, 10.1161/CIRCULATIONAHA.104.523472 · doi:10.1161/circulationaha.104.523472
  13. 10.1016/j.athoracsur.2010.03.103 · DOI
  14. 10.1016/j.jtcvs.2003.09.010 · doi:10.1016/j.jtcvs.2003.09.010
  15. Christenson JT, 1995, J Heart Valve Dis, 4, 484
  16. 10.1161/CIRCULATIONAHA.108.842104 · doi:10.1161/circulationaha.108.842104
  17. 10.1111/j.1540-8175.2006.00163.x · doi:10.1111/j.1540-8175.2006.00163.x
  18. 10.1016/j.jtcvs.2008.12.023 · doi:10.1016/j.jtcvs.2008.12.023
  19. 10.1161/01.CIR.0000138196.06772.4e · DOI · Paper page
  20. 10.1016/j.jtcvs.2011.10.029 · DOI · Paper page
  21. 10.1016/j.athoracsur.2010.11.009 · DOI · Paper page
  22. 10.1016/j.jtcvs.2011.05.006 · doi:10.1016/j.jtcvs.2011.05.006
  23. 10.1016/S0894-7317(03)00335-3 · DOI · Paper page
  24. 10.2307/2530245 · DOI · Paper page
  25. 10.2307/2336502 · DOI · Paper page
  26. 10.1161/hc37t1.094706 · doi:10.1161/hc37t1.094706
  27. 10.1161/CIRCULATIONAHA.111.072256 · DOI · Paper page
  28. 10.1161/CIRCULATIONAHA.105.000398 · DOI
  29. 10.1016/j.athoracsur.2008.05.017 · doi:10.1016/j.athoracsur.2008.05.017
  30. 10.1016/S1010-7940(01)00770-9 · doi:10.1016/s1010-7940(01)00770-9
  31. 10.1016/j.athoracsur.2005.03.034 · doi:10.1016/j.athoracsur.2005.03.034
  32. 10.1016/j.athoracsur.2004.11.005 · doi:10.1016/j.athoracsur.2004.11.005
  33. 10.1016/j.jacc.2011.08.009 · DOI · Paper page
  34. 10.1016/j.jtcvs.2012.09.007 · DOI · Paper page
  35. 10.1016/j.jtcvs.2008.11.010 · DOI · Paper page
  36. 10.1161/CIRCULATIONAHA.112.143818 · DOI · Paper page
  37. 10.1161/01.CIR.76.1.44 · DOI · Paper page
  38. 10.1054/j.cardfail.2003.09.001 · DOI
  39. 10.1054/jcaf.2003.22 · DOI

Cited by

See all 421

Metadata

Authors
Smith, P. K., Puskas, J. D., Ascheim, D. D., Voisine, P., Gelijns, A. C., Moskowitz, A. J., Hung, J. W., Parides, M. K., Ailawadi, G., Perrault, L. P., Acker, M. A., Argenziano, M., Thourani, V., Gammie, J. S., Miller, M. A., Pagé, P., Overbey, J. R., Bagiella, E., Dagenais, F., Blackstone, E. H., Kron, I. L., Goldstein, D. J., Rose, E. A., Moquete, E. G., Jeffries, N., Gardner, T. J., O'Gara, P. T., Alexander, J. H., & Michler, R. E.
Venue
New England Journal of Medicine
Published
2014-12-04
Volume
371
Issue
23
Pages
2178-2188
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W2160191160
Cited by
421
References
3
FWCI
34.12
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Surgical Treatment of Moderate Ischemic Mitral Regurgitation. https://app.cochat.ai/papers/10.1056/nejmoa1410490
The paper
Smith, P. K., Puskas, J. D., Ascheim, D. D., Voisine, P., Gelijns, A. C., Moskowitz, A. J., Hung, J. W., Parides, M. K., Ailawadi, G., Perrault, L. P., Acker, M. A., Argenziano, M., Thourani, V., Gammie, J. S., Miller, M. A., Pagé, P., Overbey, J. R., Bagiella, E., Dagenais, F., . . . Michler, R. E. (2014). Surgical Treatment of Moderate Ischemic Mitral Regurgitation. New England Journal of Medicine. https://doi.org/10.1056/nejmoa1410490

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.